Glucagon receptor antagonists-3

Name: Glucagon receptor antagonists-3
Brand: MedChemExpress
SKU: HY-50159
Rating: 4.5 (1 reviews)

Cat. No.: HY-50159 Purity: 98.52%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Glucagon receptor antagonists-3 is a highly potent glucagon receptor antagonist.

For research use only. We do not sell to patients.

Glucagon receptor antagonists-3 Chemical Structure

CAS No. : 202917-17-7

Size	Price	Stock	Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	USD 298	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	USD 298	In-stock	Estimated Time of Arrival: December 31
Solid
5 mg	USD 271	In-stock	Estimated Time of Arrival: December 31
10 mg	USD 462	In-stock	Estimated Time of Arrival: December 31
50 mg		Get quote
100 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Glucagon receptor antagonists-3:

Glucagon receptor antagonists-2 In-stock

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

Glucagon receptor antagonists-3 is a highly potent glucagon receptor antagonist.

Molecular Weight

359.49

Formula

C₂₂H₃₀FNO₂

CAS No.

202917-17-7

Appearance

Solid

Color

White to off-white

SMILES

CC(C)C1=NC(C(C)C)=C(CCC)C(C2=CC=C(F)C=C2O)=C1[C@H](O)C.[relative stereochemistry]

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	2 years
	-20°C	1 year

Solvent & Solubility

In Vitro:

DMSO : ≥ 100 mg/mL (278.17 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.7817 mL	13.9086 mL	27.8172 mL
5 mM	0.5563 mL	2.7817 mL	5.5634 mL
10 mM	0.2782 mL	1.3909 mL	2.7817 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 3 mg/mL (8.35 mM); Clear solution

This protocol yields a clear solution of ≥ 3 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (30.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 3 mg/mL (8.35 mM); Clear solution

This protocol yields a clear solution of ≥ 3 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (30.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 98.52%

Select Batch:

Data Sheet (277 KB) SDS (252 KB)

COA (253 KB) RP-HPLC (252 KB)

Handling Instructions (2659 KB)

References

[1]. Ladouceur, Gaetan H. et al. Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists. Bioorganic & Medicinal Chemistry Letters (2002), 12(23), 3421-3424. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.7817 mL	13.9086 mL	27.8172 mL	69.5430 mL
	5 mM	0.5563 mL	2.7817 mL	5.5634 mL	13.9086 mL
	10 mM	0.2782 mL	1.3909 mL	2.7817 mL	6.9543 mL
	15 mM	0.1854 mL	0.9272 mL	1.8545 mL	4.6362 mL
	20 mM	0.1391 mL	0.6954 mL	1.3909 mL	3.4771 mL
	25 mM	0.1113 mL	0.5563 mL	1.1127 mL	2.7817 mL
	30 mM	0.0927 mL	0.4636 mL	0.9272 mL	2.3181 mL
	40 mM	0.0695 mL	0.3477 mL	0.6954 mL	1.7386 mL
	50 mM	0.0556 mL	0.2782 mL	0.5563 mL	1.3909 mL
	60 mM	0.0464 mL	0.2318 mL	0.4636 mL	1.1590 mL
	80 mM	0.0348 mL	0.1739 mL	0.3477 mL	0.8693 mL
	100 mM	0.0278 mL	0.1391 mL	0.2782 mL	0.6954 mL